Actuate Therapeutics Inc (ACTU) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Actuate Therapeutics Inc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -5.79x | -5.69x | -5.23x | -6.42x |
| P/B Ratio | 16.24x | 1490.96x | -1.30x | 8.73x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||
| Current Ratio | 2.39x | 1.05x | 0.43x | 4.71x |
| Quick Ratio | 2.39x | 1.05x | 0.43x | 4.71x |
| Leverage | ||||
| Debt/Equity | 0.05x | 0.00x | 0.00x | 0.03x |
YoY = year-over-year change. Source: FMP..